Fischer Medical Ventures Limited has informed the exchange on the outcome of Postal ballot and the scrutinizer report
FISCHER · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Fischer Medical Ventures Limited conducted a Postal Ballot (remote e-voting) that concluded on May 3, 2025, seeking shareholder approval for one Special Resolution. The resolution was to appoint Ms. Jaya Ankur Singhania (DIN: 01990322) as an Independent Director of the company. The resolution was passed with near-unanimous support: 40,076,265 votes (99.99%) were cast in favour out of 40,076,275 total votes polled, which represented 62.81% of the company's 63,801,547 outstanding shares. Promoters and promoter group voted 100% in favour with all 40,076,265 of their shares; only 10 shares from public non-institutional shareholders were voted against. Scrutinizer Nuren Lodaya (Nuren Lodaya & Associates) certified the result on May 5, 2025, confirming the resolution was passed with the requisite majority.
This is a routine corporate governance update with no direct material impact on financials or stock price. The overwhelming approval (99.99% in favour) reflects strong shareholder alignment, and the new Independent Director addition may strengthen board oversight going forward.